Lack of effect of ustekinumab in treatment of allergic contact dermatitis
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Allergic contact dermatitis is a chronic inflammatory T cell mediated disease that can be recalcitrant to existing treatments. Ustekinumab is a monocloncal antibody blocking IL-12 and IL-23, shown to be effective and safe for patients with psoriasis. Despite both IL-12 and IL-23 involvement in contact allergy, the effect of Ustekinumab on allergic contact dermatitis has not been reported.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Contact Dermatitis |
Vol/bind | 65 |
Udgave nummer | 4 |
Sider (fra-til) | 227-30 |
Antal sider | 4 |
ISSN | 0105-1873 |
DOI | |
Status | Udgivet - 1 okt. 2011 |
ID: 40179388